SCM
ABBV icon

Smith Capital Management’s AbbVie ABBV Stock Holding History

Smith Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$214K Hold
2,445
– – 0.13% 78
2020
Q2 		$240K Buy
+2,445
New +$215K 0.16% 73
2020
Q1 		– Sell
-2,359
Closed -$209K – 81
2019
Q4 		$209K Buy
+2,359
New +$196K 0.13% 79

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Smith Capital Management's ABBV Position: Q3 2020 in Review

Smith Capital Management held its AbbVie (ABBV) position steady in Q3 2020 at 2,445 shares worth $214K. The position accounts for 0.13% of the portfolio, ranked #78.

Smith Capital Management first reported a position in ABBV in Q4 2019 and has held it in 3 quarters since. The position peaked at $240K in Q2 2020. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • Smith Capital Management held 2,445 shares of AbbVie worth $214K as of Q3 2020.
  • Smith Capital Management left its AbbVie share count unchanged in Q3 2020.
  • AbbVie made up 0.13% of Smith Capital Management's portfolio in Q3 2020, its #78 holding.
  • Smith Capital Management first reported a position in AbbVie in Q4 2019 and has held it in 3 quarters since.
  • Smith Capital Management's AbbVie position peaked at $240K in Q2 2020.
  • 2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Smith Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.